A 0 1 0 1 O
serious 2 9 2 9 O
uncontrolled 10 22 10 22 O
medical 23 30 23 30 B-chronic_disease
disorder 31 39 31 39 I-chronic_disease
that 40 44 40 44 O
in 45 47 45 47 O
the 48 51 48 51 O
opinion 52 59 52 59 O
of 60 62 60 62 O
the 63 66 63 66 O
investigator 67 79 67 79 O
would 80 85 80 85 O
impair 86 92 86 92 O
the 93 96 93 96 O
ability 97 104 97 104 O
of 105 107 105 107 O
the 108 111 108 111 O
subject 112 119 112 119 O
to 120 122 120 122 O
receive 123 130 123 130 O
protocol 131 139 131 139 B-treatment
therapy 140 147 140 147 I-treatment

Diagnosed 0 9 148 157 O
with 10 14 158 162 O
Mantle 15 21 163 169 B-cancer
Cell 22 26 170 174 I-cancer
Lymphoma 27 35 175 183 I-cancer
and 36 39 184 187 O
has 40 43 188 191 O
had 44 47 192 195 O
at 48 50 196 198 O
least 51 56 199 204 O
one 57 60 205 208 B-lower_bound
chemotherapy 61 73 209 221 B-treatment

ECOG 0 4 222 226 B-clinical_variable
Performance 5 16 227 238 I-clinical_variable
Status 17 23 239 245 I-clinical_variable
of 24 26 246 248 O
0 27 28 249 250 B-lower_bound
- 28 29 250 251 O
2 29 30 251 252 B-upper_bound

Known 0 5 253 258 O
CNS 6 9 259 262 O
lymphoma 10 18 263 271 B-cancer

Known 0 5 272 277 O
active 6 12 278 284 O
Hepatitis 13 22 285 294 B-chronic_disease
B 23 24 295 296 I-chronic_disease
or 25 27 297 299 O
Hepatitis 28 37 300 309 B-chronic_disease
C 38 39 310 311 I-chronic_disease

Must 0 4 312 316 O
be 5 7 317 319 O
referred 8 16 320 328 O
for 17 20 329 332 O
treatment 21 30 333 342 B-treatment
with 31 35 343 347 I-treatment
ibrutinib 36 45 348 357 I-treatment

Prior 0 5 358 363 O
malignancy 6 16 364 374 B-cancer
( 17 18 375 376 O
except 18 24 376 382 O
nonmelanomatous 25 40 383 398 B-cancer
skin 41 45 399 403 I-cancer
cancer 46 52 404 410 I-cancer
) 52 53 410 411 O
unless 54 60 412 418 O
disease 61 68 419 426 O
free 69 73 427 431 O
for 74 77 432 435 O
a 78 79 436 437 O
minimum 80 87 438 445 O
of 88 90 446 448 O
2 91 92 449 450 B-lower_bound
years 93 98 451 456 I-lower_bound

Significant 0 11 457 468 O
history 12 19 469 476 O
of 20 22 477 479 O
heart 23 28 480 485 B-chronic_disease
disease 29 36 486 493 I-chronic_disease

Subject 0 7 494 501 O
has 8 11 502 505 O
an 12 14 506 508 O
active 15 21 509 515 B-chronic_disease
infection 22 31 516 525 I-chronic_disease

Subject 0 7 526 533 O
has 8 11 534 537 O
known 12 17 538 543 O
contraindication 18 34 544 560 O
or 35 37 561 563 O
allergy 38 45 564 571 O
to 46 48 572 574 O
both 49 53 575 579 O
xanthine 54 62 580 588 B-allergy_name
oxidase 63 70 589 596 I-allergy_name
inhibitors 71 81 597 607 I-allergy_name
and 82 85 608 611 O
rasburicase 86 97 612 623 B-allergy_name

Subject 0 7 624 631 O
has 8 11 632 635 O
malabsorption 12 25 636 649 B-chronic_disease
syndrome 26 34 650 658 I-chronic_disease
or 35 37 659 661 O
other 38 43 662 667 O
condition 44 53 668 677 O
which 54 59 678 683 O
may 60 63 684 687 O
affect 64 70 688 694 O
an 71 73 695 697 O
enteral 74 81 698 705 O
route 82 87 706 711 O
of 88 90 712 714 O
administration 91 105 715 729 O

Subject 0 7 730 737 O
is 8 10 738 740 O
at 11 13 741 743 O
high 14 18 744 748 O
risk 19 23 749 753 O
for 24 27 754 757 O
TLS 28 31 758 761 B-cancer

Subject 0 7 762 769 O
is 8 10 770 772 O
pregnant 11 19 773 781 B-pregnancy

non 0 3 782 785 O
- 3 4 785 786 O
invasive 4 12 786 794 O
conditions 13 23 795 805 O
such 24 28 806 810 O
as 29 31 811 813 O
carcinoma 32 41 814 823 B-cancer
in 42 44 824 826 I-cancer
situ 45 49 827 831 I-cancer
of 50 52 832 834 I-cancer
the 53 56 835 838 I-cancer
breast 57 63 839 845 I-cancer
, 63 64 845 846 O
oral 65 69 847 851 B-cancer
cavity 70 76 852 858 I-cancer
, 76 77 858 859 O
or 78 80 860 862 O
cervix 81 87 863 869 B-cancer
are 88 91 870 873 O
all 92 95 874 877 O
permissible 96 107 878 889 O

